Benchmarking the outcomes of single-stage augmentation mastopexy against primary breast augmentation: a single surgeon's experience of 905 consecutive cases.

Montemurro, Paolo and Cheema, Mubashir and Hedén, Per and Behr, Björn and Wallner, Christoph (2019) Benchmarking the outcomes of single-stage augmentation mastopexy against primary breast augmentation: a single surgeon's experience of 905 consecutive cases. Plastic and reconstructive surgery. ISSN 1529-4242. This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs

Full text not available from this repository.
Official URL: http://ovidsp.dc1.ovid.com/sp-3.33.0b/ovidweb.cgi?...

Abstract

BACKGROUND

Augmentation mastopexy may be performed as a one or a two-stage procedure. Due to the opposing force vectors involved in the augmentation and in mastopexy, some surgeons advocate a two-stage procedure. The literature appears divided on whether a single or two-stage operation has a more favorable complications profile. The purpose of this review was to benchmark the outcomes of single-stage augmentation mastopexy (SAM) against those of a commonly performed aesthetic breast surgery operation (primary breast augmentation, BA) performed by the same surgeon, in the same setting and over the same period.

METHODS

We reviewed electronic patient records of all consecutive female patients who underwent single-stage augmentation mastopexy and primary breast augmentation by the first author (P.M.) at our clinic, between April 2009 and May 2017 and had at least a 6 months' follow-up. The notes were analysed for patient demographics, implant characteristics and complications. Data from single-stage augmentation mastopexy was benchmarked against the outcomes of primary breast augmentations performed by the same surgeon, in the same time period and at the same clinic.

RESULTS

104 single-stage augmentation mastopexies and 801 primary breast augmentations were performed during this period with a mean follow-up of 15.4 months and 14.0 months respectively. The patients undergoing augmentation mastopexy were significantly more likely to be older, have a relatively higher BMI, have more children on average and were significantly less likely to use oral contraceptives. There was no statistically significant difference in the overall complication rate between patients who had single-stage augmentation mastopexy or primary breast augmentation.

CONCLUSION

Our experience suggests that single-stage augmentation mastopexy has comparable outcomes to those of primary breast augmentation. Smokers were more likely to have a re-operation due to postoperative complication (seroma), but the rate of implant change was not different.

Item Type: Article
Additional Information: This article is available to all UHB staff and students via ASK Discovery tool http://tinyurl.com/z795c8c by using their UHB Athens login IDs
Subjects: WO Surgery
WP Gynaecology. Women’s health
Divisions: Planned IP Care > General Surgery
Related URLs:
Depositing User: Miss Emily Johnson
Date Deposited: 24 Jun 2019 12:57
Last Modified: 24 Jun 2019 12:57
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/2178

Actions (login required)

View Item View Item